Back to search

Boston University

Succinylation as a post translational modification in chronic traumatic encephalopathy

Abstract

dc:description.abstract

The extensive function of proteins in the human body is further expanded through specific post-translational modifications of these proteins. One such modification is succinylation, where a succinyl group is added to a lysine residue on a protein, adding considerable mass and changing the charge to net negative. Succinylation can occur through both enzymatic and nonenzymatic mechanisms, one such enzymatic mechanism being through the enzyme alpha-ketoglutarate dehydrogenase complex (KGDHC). The succinylation of the protein tau may result in the formation of neurofibrillary tangles, a key marker of a wide variety of neurodegenerative diseases, including chronic traumatic encephalopathy (CTE), which is a specific neurodegenerative disease that results from repetitive head trauma. Identifying the changes that occur in the brain due to these repetitive hits to the head is key to expanding our knowledge of CTE. This research project aims to measure succinylated tau in post-mortem brain tissue from those with CTE, AD, and no significant pathology (controls). It was found that in the dorsolateral frontal part of the cortex, those diagnosed with CTE stages III/IV have a significantly higher amount of succinylated tau when compared to a group that had no exposure history to contact sports. It was also found that longer years of contact sports history were linked to higher levels of succinylated tau. To understand the mechanism of this increased level of succinylated tau seen in higher CTE stages, the activity of the protein KGDHC was measured in these brain samples, as KGDHC is a known succinylator. The activity of KGDHC was found to have no statistically significant difference in CTE stages III/IV and Alzheimer’s brain tissue compared to the controls, revealing that KGDHC is an unlikely cause of the increased succinylation of tau seen. This means that other potential nonenzymatic and enzymatic mechanisms of succinylation could be at play in the brain of individuals diagnosed with CTE. Overall, these findings provide the first indication that succinylation could be a key modification involved in the neurodegenerative disease CTE. This opens the door for exploring other succinylated proteins, the localization of succinylated tau, and further differences between stages of CTE and succinylated tau. This succinylation research will help find key ways to diagnose CTE during life, potentially acting as a biomarker, which could lead to the development of novel treatments for the disease.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Biology
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hansen, Grace E.
Advisor dc:contributor.advisor
  • Stein, Thor

Subjects

dc:subject × 8

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/53417

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Hansen, Grace E.. Succinylation as a post translational modification in chronic traumatic encephalopathy. masters thesis, Boston University, 2025. https://hdl.handle.net/2144/53417